- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
- 4 x OXL: OXALATE ION(Non-covalent)
OXL.2: 9 residues within 4Å:- Chain A: R.87, K.186, E.188, A.209, R.210, G.211, D.212, T.244
- Ligands: MG.3
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:E.188, A:G.211, A:D.212
- Salt bridges: A:R.87, A:K.186
OXL.7: 8 residues within 4Å:- Chain B: K.186, E.188, A.209, R.210, G.211, D.212, T.244
- Ligands: MG.8
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:E.188, B:G.211, B:D.212, B:T.244, B:T.244, B:T.244
- Salt bridges: B:R.87, B:K.186
OXL.12: 8 residues within 4Å:- Chain C: K.186, E.188, A.209, R.210, G.211, D.212, T.244
- Ligands: MG.13
11 PLIP interactions:11 interactions with chain C- Hydrogen bonds: C:G.211, C:D.212, C:D.212, C:T.244, C:T.244, C:T.244
- Water bridges: C:R.87, C:K.186
- Salt bridges: C:R.87, C:K.186, C:K.186
OXL.17: 9 residues within 4Å:- Chain D: R.87, K.186, E.188, A.209, R.210, G.211, D.212, T.244
- Ligands: MG.18
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:E.188, D:G.211, D:D.212
- Salt bridges: D:R.87, D:K.186, D:K.186
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 3 residues within 4Å:- Chain A: E.188, D.212
- Ligands: OXL.2
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.188, A:D.212
MG.8: 3 residues within 4Å:- Chain B: E.188, D.212
- Ligands: OXL.7
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:E.188, B:D.212, H2O.9
MG.13: 4 residues within 4Å:- Chain C: K.186, E.188, D.212
- Ligands: OXL.12
4 PLIP interactions:2 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.188, C:D.212, H2O.16, H2O.17
MG.18: 3 residues within 4Å:- Chain D: E.188, D.212
- Ligands: OXL.17
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:E.188, D:D.212
- 4 x K: POTASSIUM ION(Non-covalent)
K.4: 5 residues within 4Å:- Chain A: N.89, S.91, D.127, T.128, S.159
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:S.91, A:D.127, A:T.128
K.9: 6 residues within 4Å:- Chain B: N.89, S.91, D.127, T.128, S.159, K.186
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:S.91, B:D.127, B:T.128
K.14: 6 residues within 4Å:- Chain C: N.89, S.91, D.127, T.128, S.159, K.186
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:S.91, C:D.127, C:T.128
K.19: 6 residues within 4Å:- Chain D: N.89, S.91, D.127, T.128, S.159, K.186
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:S.91, D:D.127, D:T.128
- 3 x I9F: dimethyl (2R)-2-hydroxy-2-{2-[4-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperazin-1-yl]-2-oxoethyl}butanedioate(Non-covalent)
I9F.5: 12 residues within 4Å:- Chain A: T.64, P.67, R.87, N.89, H.92, G.93, Y.97, H.98, S.278, G.279, A.282, K.283
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:P.67, A:N.89, A:H.92, A:Y.97, A:A.282
- Hydrogen bonds: A:R.87, A:N.89, A:K.283
- Salt bridges: A:H.92
- pi-Cation interactions: A:H.92
I9F.10: 12 residues within 4Å:- Chain B: T.64, P.67, N.89, S.91, H.92, G.93, Y.97, H.98, S.278, G.279, A.282, K.283
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:P.67, B:N.89, B:Y.97, B:A.282
- Hydrogen bonds: B:R.87, B:N.89
- Salt bridges: B:H.92
- pi-Cation interactions: B:H.92
I9F.15: 14 residues within 4Å:- Chain C: T.64, I.65, P.67, R.87, N.89, S.91, H.92, G.93, Y.97, H.98, S.278, G.279, A.282, K.283
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:T.64, C:N.89, C:H.92, C:Y.97, C:A.282
- Hydrogen bonds: C:R.87, C:N.89, C:K.283
- Water bridges: C:G.279
- pi-Stacking: C:H.92, C:H.92
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nain-Perez, A. et al., Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase. Eur.J.Med.Chem. (2022)
- Release Date
- 2022-03-16
- Peptides
- Pyruvate kinase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
SMTL ID : 5sci.2 (1 other biounit)
Structure of liver pyruvate kinase in complex with anthraquinone derivative 105
Pyruvate kinase
Related Entries With Identical Sequence
5sc8.1 | 5sc8.2 | 5sc9.1 | 5sc9.2 | 5sca.1 | 5sca.2 | 5scb.1 | 5scb.2 | 5scc.1 | 5scc.2 | 5scd.1 | 5scd.2 | 5sce.1 | 5sce.2 | 5scf.1 | 5scf.2 | 5scg.1 | 5scg.2 | 5sch.1 | 5sch.2 | 5sci.1 | 5scj.1 | 5scj.2 | 5sck.1 | 5sck.2 | 5scl.1 | 5scl.2 | 5sdt.1 | 5sdt.2 | 7frv.1 more...less...7frv.2 | 7frw.1 | 7frw.2 | 7frx.1 | 7frx.2 | 7fry.1 | 7fry.2 | 7frz.1 | 7frz.2 | 7fs0.1 | 7fs0.2 | 7fs1.1 | 7fs1.2 | 7fs2.1 | 7fs2.2 | 7fs3.1 | 7fs3.2 | 7fs4.1 | 7fs4.2 | 7fs5.1 | 7fs5.2 | 7fs6.1 | 7fs6.2 | 7fs7.1 | 7fs7.2 | 7fs8.1 | 7fs8.2 | 7fs9.1 | 7fs9.2 | 7fsa.1 | 7fsa.2 | 7fsb.1 | 7fsb.2 | 7fsc.1 | 7fsc.2 | 7fsd.1 | 7fsd.2 | 7qdn.1 | 7qdn.2 | 7qzu.1 | 7qzu.2